DIVE, DIVE, DIVE!! Patience will last only one mo
Post# of 11803
(Total Views: 275)
Posted On: 11/15/2017 10:07:15 AM
DIVE, DIVE, DIVE!!
Patience will last only one more quarter.
Berman named Class Action back in June 1997. Attorney's for the Plaintiffs.
MILBERG WEISS BERSHAD ORIGINAL HYNES & LERACH LLP
WILLIAM S. LERACH (68581)
PATRICK J. COUGHLIN (111070)
HENRY ROSEN (156963)
KRISTEN McCULLOCH (177558)
600 West Broadway, Suite 1800
San Diego, CA 92101
Telephone: 619/231-1058
EUGENE MIKOLAJCZYK (106929)
1165 N. Bienveneda
Pacific Palisades, CA 90272
Telephone: 310/454-8435
WECHSLER HARWOOD HALEBIAN
& FEFFER LLP
ROBERT I. HARWOOD
RICHARD B. BRUALDI
805 Third Avenue
7th Floor
New York, NY 10022
Telephone: 212/935-7400
DEFENDENTS===>
STEVEN E. LEVY, KEITH M. BERMAN,
JAMES J. KEEGAN, JOHN D. GARBER,
PHILIP BECTON, CORBIN & WERTZ, AND
FENWICK & WEST,
Defendants
Just the beginning of the filing ====>
SUMMARY OF ACTION
2 1. This is an individual and class action on behalf of all
3 persons who purchased the securities of Access HealthNet, Inc.
4 ("Access HealthNet" or the "Company"
, between January 25, 1995 and
5 December 29, 1995 (the "Class Period" , seeking to pursue remedies
6 under Sections 10(b) and 20(a) of the Securities Exchange Act of
7 1934 ("Exchange Act" and Rule 10b-5 promulgated thereunder (the
8 "Class". This action involves a course of conduct by Access
9 HealthNet insiders, officers and directors of the Company, the
10 Company's auditors and United States Securities and Exchange
11 Commission ("SEC" counsel that was designed to and did defraud
12 those who purchased Access HealthNet securities during the Class
13 Period.
14 2. This case involves defendants' use of manipulative
15 devices and their dissemination of false financial statements and
16 other false and misleading information about Access HealthNet's
17 business, all of which was, inter alia , designed to and did:
18 (a) artificially inflate the price of Access HealthNet securities
19 during the Class Period; (b) induce investors to purchase shares of
20 Access HealthNet stock; (c) allow certain defendants to sell or
21 offer to sell millions of dollars of their own Access HealthNet
22 shares at artificially inflated levels; and (d) allow defendants to
23 sell or offer to sell millions of dollars of Access HealthNet
24 securities to private investors in various private placement
25 transactions.
Patience will last only one more quarter.
Berman named Class Action back in June 1997. Attorney's for the Plaintiffs.
MILBERG WEISS BERSHAD ORIGINAL HYNES & LERACH LLP
WILLIAM S. LERACH (68581)
PATRICK J. COUGHLIN (111070)
HENRY ROSEN (156963)
KRISTEN McCULLOCH (177558)
600 West Broadway, Suite 1800
San Diego, CA 92101
Telephone: 619/231-1058
EUGENE MIKOLAJCZYK (106929)
1165 N. Bienveneda
Pacific Palisades, CA 90272
Telephone: 310/454-8435
WECHSLER HARWOOD HALEBIAN
& FEFFER LLP
ROBERT I. HARWOOD
RICHARD B. BRUALDI
805 Third Avenue
7th Floor
New York, NY 10022
Telephone: 212/935-7400
DEFENDENTS===>
STEVEN E. LEVY, KEITH M. BERMAN,
JAMES J. KEEGAN, JOHN D. GARBER,
PHILIP BECTON, CORBIN & WERTZ, AND
FENWICK & WEST,
Defendants
Just the beginning of the filing ====>
SUMMARY OF ACTION
2 1. This is an individual and class action on behalf of all
3 persons who purchased the securities of Access HealthNet, Inc.
4 ("Access HealthNet" or the "Company"
, between January 25, 1995 and 5 December 29, 1995 (the "Class Period"
, seeking to pursue remedies 6 under Sections 10(b) and 20(a) of the Securities Exchange Act of
7 1934 ("Exchange Act"
and Rule 10b-5 promulgated thereunder (the 8 "Class"
. This action involves a course of conduct by Access 9 HealthNet insiders, officers and directors of the Company, the
10 Company's auditors and United States Securities and Exchange
11 Commission ("SEC"
counsel that was designed to and did defraud 12 those who purchased Access HealthNet securities during the Class
13 Period.
14 2. This case involves defendants' use of manipulative
15 devices and their dissemination of false financial statements and
16 other false and misleading information about Access HealthNet's
17 business, all of which was, inter alia , designed to and did:
18 (a) artificially inflate the price of Access HealthNet securities
19 during the Class Period; (b) induce investors to purchase shares of
20 Access HealthNet stock; (c) allow certain defendants to sell or
21 offer to sell millions of dollars of their own Access HealthNet
22 shares at artificially inflated levels; and (d) allow defendants to
23 sell or offer to sell millions of dollars of Access HealthNet
24 securities to private investors in various private placement
25 transactions.
(0)
(0)